Lv4
510 积分 2025-05-08 加入
KRAS-G12D inhibitor HRS-4642 plus chemotherapy in advanced KRASG12D-mutant pancreatic cancer: a phase 1b/2 trial
6天前
已完结
Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer – A GISCAD phase II randomized trial
2个月前
已完结
Benefit of Chemoradiotherapy Versus Chemotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer: The Randomized CONKO-007 Trial
2个月前
已完结
[A real-world study of first-line albumin-bound paclitaxel in the treatment of advanced pancreatic cancer in China]
2个月前
已完结
Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study
2个月前
已完结
Pancreatic cancer
4个月前
已完结
Thromboembolism
6个月前
已关闭
Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients. Thromb Haemost
6个月前
已完结
Natural history of venous thromboembolism
6个月前
已完结
Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer
9个月前
已完结
皖公网安备34019202002308
